journal article·2025-04-23

Rapid and Accurate Quantification of RNA in Lipid Nanoparticles by Scatter-Free UV/Visible Spectroscopy

Eric C. Le Ru, Roland Böttger, Darren Andrews, Patrick Baumhof, Jelena V. Rakonjac, Geoffry Laufersky, Brendan L. Darby

Nano Letters· Volume 25· Issue 16
Publisher page

Abstract

UV/visible spectroscopy is the method of choice for RNA quantification, thanks to its simplicity and accuracy. However, it cannot be used to quantify RNA in lipid nanoparticles (LNPs), such as those used for drug delivery in mRNA vaccines, because of light scattering by LNPs. Alternative methods such as the RiboGreen fluorescence assay require much more sample preparation and lack reproducibility and accuracy. Here we propose and demonstrate an alternative approach using an integrating sphere setup to measure scatter-free absorption spectra. RNA spectra of RNA-loaded LNPs can then be directly measured, and the total RNA concentration can be deduced. The method shows very good linearity and precision (∼1.5%), and the accuracy is estimated to be ∼5% when applied to various mRNA-LNP formulations. This work paves the way for the routine characterization of payload concentration in LNP formulation research.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Spectroscopy Techniques in Biomedical and Chemical Research · Lipid Membrane Structure and Behavior · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Marama Labs Limited, 32 Salamanca Road, Wellington, 6012, New Zealand

The MacDiarmid Institute for Advanced Materials and Nanotechnology, School of Chemical and Physical Sciences

Victoria University of Wellington

CureVac SE

Marama Labs Limited, DCU Alpha, Old Glasnevin Road, Dublin, D11KXN4, Ireland

Funding

Marsden Fund

References (32)

Show source-provided references
1. 10.1021/acsnano.1c0499610.1021/acsnano.1c04996 ↗
2. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
3. Lutz J. · npj Vaccines · 2017 · 2 · 2910.1038/s41541-017-0032-6 ↗
4. 10.1016/j.ijpharm.2021.12058610.1016/j.ijpharm.2021.120586 ↗
5. 10.1021/acs.nanolett.8b0110110.1021/acs.nanolett.8b01101 ↗
6. Berne B. J. · 2000
7. 10.1007/s12551-016-0218-610.1007/s12551-016-0218-6 ↗
8. 10.1016/j.jconrel.2019.02.03010.1016/j.jconrel.2019.02.030 ↗
9. 10.1093/nar/gnh01510.1093/nar/gnh015 ↗
10. 10.1016/j.omtn.2024.10217110.1016/j.omtn.2024.102171 ↗
11. 10.1016/j.ijleo.2017.08.03110.1016/j.ijleo.2017.08.031 ↗
12. 10.1016/j.virol.2010.08.01510.1016/j.virol.2010.08.015 ↗
13. 10.1016/j.ab.2023.11526910.1016/j.ab.2023.115269 ↗
14. 10.1016/j.jconrel.2024.01.03710.1016/j.jconrel.2024.01.037 ↗
15. 10.1016/j.jpba.2020.11364210.1016/j.jpba.2020.113642 ↗
16. 10.1016/j.jconrel.2022.05.02010.1016/j.jconrel.2022.05.020 ↗
17. 10.1016/j.jconrel.2021.10.03110.1016/j.jconrel.2021.10.031 ↗
18. 10.1021/acsnano.2c0564710.1021/acsnano.2c05647 ↗
19. 10.1038/s41598-024-52685-110.1038/s41598-024-52685-1 ↗
20. 10.1364/AO.31.00205510.1364/AO.31.002055 ↗
21. 10.1007/BF0269269410.1007/BF02692694 ↗
22. 10.1364/AO.42845010.1364/AO.428450 ↗
23. 10.1364/AO.32.00671010.1364/AO.32.006710 ↗
24. 10.1364/AO.55.00303010.1364/AO.55.003030 ↗
25. 10.4319/lo.2002.47.3.091110.4319/lo.2002.47.3.0911 ↗
26. 10.1364/AO.42.00480210.1364/AO.42.004802 ↗
27. 10.1016/j.jphotobiol.2005.10.00210.1016/j.jphotobiol.2005.10.002 ↗
28. 10.6028/jres.114.00610.6028/jres.114.006 ↗
29. 10.1021/jp047564010.1021/jp0475640 ↗
30. 10.1038/nphoton.2015.20510.1038/nphoton.2015.205 ↗
31. 10.1021/acs.analchem.9b0379810.1021/acs.analchem.9b03798 ↗
32. 10.1021/acsnano.0c0843110.1021/acsnano.0c08431 ↗